ALHC
Alignment HealthcareBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-20
Current thesis
Strong Q1 growth and raised guidance could support a re-rating if Q2 confirms membership, margin, and EBITDA execution. The reported median analyst target is $24.9231, but analyst count is unavailable.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
Analyst estimate revisions, target changes, and consensus surprise data are unavailable.
Momentum
74
Value
53
Sentiment
51
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $20.00 · Bull $24.90 · Bear $16.50
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-07-16 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $24.92
Why
Momentum74 · Δ7d -21.3
Value53 · Δ7d -0.3
Sentiment51 · Δ7d -19.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Value · See fundamentals
Momentum
74
26% active weight
Current posture
7d trendSoftening
Δ7d
-21.3
Δ21d
-26.3
Value
53
39% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
+1.0
Sentiment
51
34% active weight
Current posture
7d trendSoftening
Δ7d
-19.8
Δ21d
+0.4
Why this grade
Composite grade B. Momentum 73.5 / Value 52.9 / Sentiment 50.7
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$4.36B
Beta
1.16
Shares Out
206.73M
P/E (TTM) · Derived
-5702.7
P/S (TTM)
1.16
P/FCF (TTM)
27.91
Rev YoY
+33.3%
EPS YoY
-213.8%
Gross Margin
+12.4%
Op Margin
-0.0%
Net Debt
-$239.87M
Current Ratio
1.58
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology